Tech Company Financing Transactions
Mirna Therapeutics Funding Round
On 12/31/2013, Mirna Therapeutics announced $4.8 million in funding from Sofinnova Ventures.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$4,750,000
Round
Undisclosed
Investors
Sofinnova Ventures (Michael Powell)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2150 Woodward St. 100
Austin, TX 78744
USA
Austin, TX 78744
USA
Phone
Website
Email Address
Overview
Mirna Therapeutics, Inc. (NASDAQ: MIRN) is a biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics and is the first to establish clinical proof-of-concept for a microRNA replacement therapy for cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Lammers
Chief Financial Officer
Alan Fuhrman
Chief Scientific Officer
Miguel Barbosa
VP - Finance
Jon Irvin
VP - R & D
Jay Stoudemire
Browse more venture capital transactions:
Prev: 12/31/2013: Doctor On Demand venture capital transaction
Next: 12/31/2013: Seelio venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs